Shanmugam Muruganandan1, Rajgopal Govindarajan1, Christopher J Sinal2. 1. Division of Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, Columbus, OH, USA. 2. Department of Pharmacology, Dalhousie University, 5850 College Street, Box 15000, Halifax, Nova Scotia, B3H4R2, Canada. csinal@dal.ca.
Abstract
PURPOSE OF REVIEW: To summarize and discuss recent progress and novel signaling mechanisms relevant to bone marrow adipocyte formation and its physiological/pathophysiological implications for bone remodeling. RECENT FINDINGS: Skeletal remodeling is a coordinated process entailing removal of old bone and formation of new bone. Several bone loss disorders such as osteoporosis are commonly associated with increased bone marrow adipose tissue. Experimental and clinical evidence supports that a reduction in osteoblastogenesis from mesenchymal stem cells at the expense of adipogenesis, as well as the deleterious effects of adipocyte-derived signaling, contributes to the etiology of osteoporosis as well as bone loss associated with aging, diabetes mellitus, post-menopause, and chronic drug therapy. However, this view is challenged by findings indicating that, in some contexts, bone marrow adipose tissue may have a beneficial impact on skeletal health. Further research is needed to better define the role of marrow adipocytes in bone physiology/pathophysiology and to determine the therapeutic potential of manipulating mesenchymal stem cell differentiation.
PURPOSE OF REVIEW: To summarize and discuss recent progress and novel signaling mechanisms relevant to bone marrow adipocyte formation and its physiological/pathophysiological implications for bone remodeling. RECENT FINDINGS: Skeletal remodeling is a coordinated process entailing removal of old bone and formation of new bone. Several bone loss disorders such as osteoporosis are commonly associated with increased bone marrow adipose tissue. Experimental and clinical evidence supports that a reduction in osteoblastogenesis from mesenchymal stem cells at the expense of adipogenesis, as well as the deleterious effects of adipocyte-derived signaling, contributes to the etiology of osteoporosis as well as bone loss associated with aging, diabetes mellitus, post-menopause, and chronic drug therapy. However, this view is challenged by findings indicating that, in some contexts, bone marrow adipose tissue may have a beneficial impact on skeletal health. Further research is needed to better define the role of marrow adipocytes in bone physiology/pathophysiology and to determine the therapeutic potential of manipulating mesenchymal stem cell differentiation.
Authors: Kazuhisa Nakashima; Xin Zhou; Gary Kunkel; Zhaoping Zhang; Jian Min Deng; Richard R Behringer; Benoit de Crombrugghe Journal: Cell Date: 2002-01-11 Impact factor: 41.582
Authors: Hongli Sun; Jin Koo Kim; Richard Mortensen; Lorraine P Mutyaba; Kurt D Hankenson; Paul H Krebsbach Journal: Stem Cells Date: 2013-10 Impact factor: 6.277
Authors: Marie Kveiborg; George Sabatakos; Riccardo Chiusaroli; Meilin Wu; William M Philbrick; William C Horne; Roland Baron Journal: Mol Cell Biol Date: 2004-04 Impact factor: 4.272
Authors: Thomas H Ambrosi; Antonio Scialdone; Antonia Graja; Sabrina Gohlke; Anne-Marie Jank; Carla Bocian; Lena Woelk; Hua Fan; Darren W Logan; Annette Schürmann; Luis R Saraiva; Tim J Schulz Journal: Cell Stem Cell Date: 2017-03-16 Impact factor: 24.633
Authors: Andrea B Kirk; Stephani Michelsen-Correa; Cliff Rosen; Clyde F Martin; Bruce Blumberg Journal: Endocrinology Date: 2021-12-01 Impact factor: 5.051